| Target Validation Information | |||||
|---|---|---|---|---|---|
| Target ID | T27265 | ||||
| Target Name | 5-alpha reductase | ||||
| Target Type | Successful |
||||
| Drug Potency against Target | Finasteride | Drug Info | Ki = 23 nM | [552529] | |
| Dutasteride | Drug Info | Ki = 4.3 nM | [552529] | ||
| Dutasteride + tamsulosin | Drug Info | IC50 = 6 nM | [552402] | ||
| References | |||||
| Ref 552529 | Pharmacogenetic analysis of human steroid 5 alpha reductase type II: comparison of finasteride and dutasteride. J Mol Endocrinol. 2005 Jun;34(3):617-23. | ||||
| Ref 552529 | Pharmacogenetic analysis of human steroid 5 alpha reductase type II: comparison of finasteride and dutasteride. J Mol Endocrinol. 2005 Jun;34(3):617-23. | ||||
| Ref 552402 | Dutasteride, the dual 5alpha-reductase inhibitor, inhibits androgen action and promotes cell death in the LNCaP prostate cancer cell line. Prostate. 2004 Feb 1;58(2):130-44. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.